期刊文献+

真实世界研究的方法与实践 被引量:48

Method and Practice of Real World Study
下载PDF
导出
摘要 随机对照临床试验是目前获得证据、制定诊疗策略的主要依据之一,但是,随机对照试验并不总能代表临床实践中的真实情况。真实世界研究是观察性研究,通过"真实世界样本"来反映真实世界总体。临床试验关注效力研究,而真实世界研究则关注效果研究。真实世界研究需要使用多重倾向性评分来减少协变量在组间分布的不均衡性。近年来,真实世界研究正越来越多地应用到临床研究中,可将经验医学与循证医学结合起来。临床试验和真实世界研究是承启关系,前者的结果需要后者的进一步验证及拓展,二者综合考虑才是最佳选择。 Randomized controlled trial (RCT) is so far considered as an important way to provide evidence to make up therapeutic strategy. However, sometimes it is limited to represent the authentic condition during clinical practice. Whereas, Real world study (RWS), a kind of observational studies, is applied to present the real world population through analysis of "real world sample". RCT pays more attention to efficacy trials. While RWS more concentrates on effectiveness trials. RWS requires giving propensity scores to decrease covariant malconformation among groups. In the past few years, RWS has been increasingly applied in clinical studies to integrate experience medicine with evidence-based medicine. Results of RCT need to be tested and expanded forward in real world study. Therefore, comprehensive evaluations by both RCT and RWS are supposed to be the best selection.
出处 《循证医学》 CSCD 2014年第6期364-368,共5页 The Journal of Evidence-Based Medicine
关键词 真实世界研究 随机对照临床试验 倾向性评分 效果研究 real world study randomized controlled trial propensity score effectiveness trials
  • 相关文献

参考文献14

  • 1Krum H, Schlaich M, Whitbourn R, et al. Catheter-based renal sympathetic denervation for resistant hypertension: A nmlticentre safety and proof-of-principle cohort study [Jl. Lancet, 2009,373(9671 ) : 1275-1281.
  • 2Symplicity HTN-1 Investigators. Catheter-based renal sympa- thetic denervation for resistant hypertension: Durability of blood pressure reduction out to 24 months [Jl. Hypertension, 2011,57(5) :911-917.
  • 3Krum H, Schlaich MP, Sobotka PA, et al. Percutaneous renal denervation in patients with treatment-resistant hypertension: Final 3-year report of the Symplicity HTN-I study[J]. Lancet, 2014,383 (9917) : 622-629.
  • 4Symplicity HTN-2 Investigators, Esler MD, Krum H, Sobotka PA, et al. Renal sympathetic denervation in patients with treat- ment-resistant hypertension (The Symplicity HTN-2 Trial): A randomized controlled trial[J]. Lancet, 2010,376(9756): 1903-19O9.
  • 5Esler MD, Krum H, Sehlaich M, et al. Renal sympathetic denervation for treatment of drug-resistant hypertension: One- year results from the Symplicity HTN-2 randomized, controlled trial~J]. Circulation, 2012,126(25) : 2976-2982.
  • 6Bhatt DL, Kandzari DE, O'Neill WW, et al. A controlled trial of renal denervation for resistant hypertension [J]. N Engl J Med, 2014,370(15) : 1393-1401.
  • 7Kaplan NM, Sproul LE, Mulcahy WS. Large prospective study of ramipril in patients with hypertension. CARE Investigators. [J~. Clin Ther, 1993,15(5):810-818.
  • 8李敏,时景璞,于慧会.真实世界研究与随机对照试验、单病例随机对照试验在临床治疗性研究中的关系比较[J].中华流行病学杂志,2012,33(3):342-345. 被引量:61
  • 9李敏,时景璞.疗效比较研究的方法学应用及其实施过程[J].中华流行病学杂志,2012,33(11):1184-1188. 被引量:4
  • 10Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects[J ]. Biometrika, 1983,70( 1 ) :41-55.

二级参考文献52

  • 1Austin PC.A critical appraisal of propensity-score matching in the medical literature between 1996 and 2003.Stat Med,2008,27:2037-2049.
  • 2Austin PC,Grootendorst P,Anderson GM.A comparison of the ability of different propensity score models to balance measured variables between treated and untreated subjects:a Monte Carlo study.Stat Med,2007,26:734-753.
  • 3Rosenbaum PR,Rubin DB.The central role of the propensity score in observational studies for causal effects.Biometrika,1983,70:41-55.
  • 4Katherine HH,Thomas AL.Propensity score modeling strategies for the causal analysis of observational data.Biostatistics,2002,2:179-193.
  • 5Austin PC,Mamdanil MM.A comparison of propensity score methods:a case-study estimating the effectiveness of post-AMI statin use.Stat Med,2006,25:2084-2106.
  • 6Ekundayo OJ,Adamopoulos C,Ahmed MI,et al.Oral potassium supplement use and outcomes in chronic heart failure:a propensity-matched study.Int J Cardiol,2009.
  • 7D'Agostino RB.Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group.Stat Med,1998,17:2265-2281.
  • 8Brookhart MA,Schneeweiss S,Rothman KJ,et al.Variable selection for propensity score models.Prac Epidemiol,2006,163:1149-1156.
  • 9Perkins SM,Tu W,Underhill MG,et al.The use of propensity scores in pharmacoepidemioiogic research.Pharmacoepidemiol Drug Safety,2000,9:93-101.
  • 10Sturmer T,Joshi M,Glynn RJ,et al.A review of the application of propensity score methods yielded increasing use,advantages in specific settings,but not substantially different estimates compared with conventional multivariable methods.J Clin Epidemiol,2006,59:437-447.

共引文献154

同被引文献629

引证文献48

二级引证文献509

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部